share_log

EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Received An Additional $8.2M From DoD Related To Closeout Of The Discontinued COVID-19 Prototype Research And Development Contract

EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Received An Additional $8.2M From DoD Related To Closeout Of The Discontinued COVID-19 Prototype Research And Development Contract

獨家:SAB 生物療法告訴賓辛加有限公司.已從國防部獲得與終止的 COVID-19 原型研究和開發合同的完成相關的額外 8.2 萬美元
Benzinga Real-time News ·  2023/01/18 07:32

EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Received An Additional $8.2M From DoD Related To Closeout Of The Discontinued COVID-19 Prototype Research And Development Contract

獨家:SAB 生物療法告訴賓辛加有限公司.已從國防部獲得與終止的 COVID-19 原型研究和開發合同的完成相關的額外 8.2 萬美元

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論